Making US poison centers a part of the solution to the COVID-19 pandemic-Reference-Cited by-同舟云学术

Making US poison centers a part of the solution to the COVID-19 pandemic

Published:2021-08-27 Issue:1 Volume:60 Page:102-114
ISSN:1556-3650
Container-title:Clinical Toxicology
language:en
Short-container-title:Clinical Toxicology

Author:

Spyker Daniel A.¹^ORCID,Bronstein Alvin C.²^ORCID,Weber Julie A.³^ORCID

Affiliation:

1. Adjunct Assistant Professor of Emergency Medicine, Oregon Health & Science University, Portland, OR, USA;

2. Emergency Medical Services, Injury Prevention System Branch, Hawaii Department of Health, Honolulu, HI, USA

3. Missouri Poison Center, SSM Health Cardinal Glennon Children’s Hospital, St. Louis, MO, USA

Publisher

Informa UK Limited

Subject

Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15563650.2021.1933510

Reference27 articles.

1. FDA. Emergency Use Authorization for Vaccines Explained; 2020 Nov [cited 2021 Jan 4]; Available from: https://www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization-vaccines-explained

2. HRSA. Countermeasures Injury Compensation Program (CICP); 2020 Nov [cited 2021 Jan 4]; Available from: https://www.hrsa.gov/cicp.

3. The US Regulatory System and COVID-19 Vaccines

4. Coalition for Epidemic Preparedness Innovations (CEPI). The Coalition for Epidemic Preparedness Innovations (CEPI) foundation takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases; 2021 [cited 2021 Jan 4]; Available from: https://cepi.net/about/whoweare/

5. Law B, Sturkenboo M. Priority List of Adverse Events of Special Interest: COVID-19 (D2.3). Safety Platform for Emergency vACcines (SPEAC), Work Package: WP2 Standards and tools V2.0. 2020. May [cited 2021 Jan 4]; Available from: https://brightoncollaboration.us/wp-content/uploads/2020/06/SPEAC_D2.3_V2.0_COVID-19_20200525_public.pdf and quarterly updates https://brightoncollaboration.us/priority-list-aesi-covid/

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An observational study of adverse drug reactions to COVID-19 vaccines reported to the New Mexico poison center hotline;Clinical Toxicology;2022-12-02